Q14004 (CDK13_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 130.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Cyclin-dependent kinase 13 EC=2.7.11.22 EC=2.7.11.23 Alternative name(s): CDC2-related protein kinase 5 Cell division cycle 2-like protein kinase 5 Cell division protein kinase 13 Short name=hCDK13 Cholinesterase-related cell division controller | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1512 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. Ref.4 Ref.9 Ref.12 Ref.18 |
| Catalytic activity | ATP + [DNA-directed RNA polymerase] = ADP + [DNA-directed RNA polymerase] phosphate. Ref.18 ATP + a protein = ADP + a phosphoprotein. Ref.18 |
| Subunit structure | Interacts with CCNL1 and CCNL2 By similarity. Interacts with C1QBP. Interacts with HIV-1 Tat. Ref.9 Ref.12 |
| Subcellular location | |
| Tissue specificity | Expressed in fetal brain, liver, muscle and in adult brain. Also expressed in neuroblastoma and glioblastoma tumors. |
| Sequence similarities | Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily. Contains 1 protein kinase domain. |
| RNA editing | |
| Sequence caution | The sequence AAA58424.1 differs from that shown. Reason: Frameshift at position 1006. The sequence AAS07490.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| C1QBP | Q07021 | 6 | EBI-6375898,EBI-347528 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q14004-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q14004-2) The sequence of this isoform differs from the canonical sequence as follows: 1079-1138: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1512 | 1512 | Cyclin-dependent kinase 13 | PRO_0000085711 | |||||
Regions | |||||||||
| Domain | 705 – 998 | 294 | Protein kinase | ||||||
| Nucleotide binding | 711 – 719 | 9 | ATP By similarity | ||||||
Sites | |||||||||
| Active site | 837 | 1 | Proton acceptor By similarity | ||||||
| Binding site | 734 | 1 | ATP By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 315 | 1 | Phosphoserine Ref.14 Ref.22 | ||||||
| Modified residue | 317 | 1 | Phosphoserine Ref.14 Ref.22 | ||||||
| Modified residue | 325 | 1 | Phosphoserine Ref.14 | ||||||
| Modified residue | 340 | 1 | Phosphoserine Ref.14 | ||||||
| Modified residue | 342 | 1 | Phosphoserine Ref.14 | ||||||
| Modified residue | 383 | 1 | Phosphoserine Ref.14 Ref.19 Ref.22 | ||||||
| Modified residue | 395 | 1 | Phosphoserine Ref.14 Ref.22 | ||||||
| Modified residue | 397 | 1 | Phosphoserine Ref.14 Ref.22 | ||||||
| Modified residue | 400 | 1 | Phosphoserine Ref.14 Ref.22 | ||||||
| Modified residue | 409 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 436 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 437 | 1 | Phosphoserine Ref.14 Ref.19 Ref.22 | ||||||
| Modified residue | 439 | 1 | Phosphoserine Ref.14 Ref.19 Ref.22 | ||||||
| Modified residue | 525 | 1 | Phosphoserine Ref.19 | ||||||
| Modified residue | 556 | 1 | N6-acetyllysine Ref.17 | ||||||
| Modified residue | 871 | 1 | Phosphothreonine Ref.14 Ref.19 Ref.22 | ||||||
| Modified residue | 1048 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1246 | 1 | Phosphothreonine Ref.8 Ref.13 Ref.22 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1079 – 1138 | 60 | Missing in isoform 2. | VSP_013579 | |||||
| Natural variant | 103 | 1 | Q → R in RNA edited version. | VAR_066526 | |||||
| Natural variant | 340 | 1 | S → F. Corresponds to variant rs13622 [ dbSNP | Ensembl ]. | VAR_053926 | |||||
| Natural variant | 356 | 1 | P → A. Ref.2 Corresponds to variant rs17537669 [ dbSNP | Ensembl ]. | VAR_022381 | |||||
| Natural variant | 403 | 1 | L → F. Ref.2 Corresponds to variant rs3735137 [ dbSNP | Ensembl ]. | VAR_022382 | |||||
| Natural variant | 410 | 1 | R → Q. Ref.2 Corresponds to variant rs17496261 [ dbSNP | Ensembl ]. | VAR_022383 | |||||
| Natural variant | 494 | 1 | T → A. Ref.23 Corresponds to variant rs34624759 [ dbSNP | Ensembl ]. | VAR_041965 | |||||
| Natural variant | 500 | 1 | T → A. Ref.2 Ref.23 Corresponds to variant rs3735135 [ dbSNP | Ensembl ]. | VAR_022384 | |||||
| Natural variant | 624 | 1 | S → G. Ref.2 Corresponds to variant rs17496275 [ dbSNP | Ensembl ]. | VAR_022385 | |||||
| Natural variant | 670 | 1 | T → R. Ref.23 Corresponds to variant rs34775357 [ dbSNP | Ensembl ]. | VAR_041966 | |||||
| Natural variant | 700 | 1 | R → L. Ref.1 Ref.4 Corresponds to variant rs1057000 [ dbSNP | Ensembl ]. | VAR_022386 | |||||
| Natural variant | 1062 | 1 | V → M. Ref.2 Corresponds to variant rs17496712 [ dbSNP | Ensembl ]. | VAR_022387 | |||||
| Natural variant | 1170 | 1 | V → M. Ref.1 Ref.23 Corresponds to variant rs3204309 [ dbSNP | Ensembl ]. | VAR_041967 | |||||
Experimental info | |||||||||
| Sequence conflict | 21 | 1 | K → R in CAC10400. Ref.1 | ||||||
| Sequence conflict | 21 | 1 | K → R in CAC10401. Ref.1 | ||||||
| Sequence conflict | 671 | 1 | A → T in CAC10400. Ref.1 | ||||||
| Sequence conflict | 671 | 1 | A → T in CAC10401. Ref.1 | ||||||
| Sequence conflict | 671 | 1 | A → T in AAA58424. Ref.4 | ||||||
| Sequence conflict | 810 | 1 | N → Y in AAA58424. Ref.4 | ||||||
| Sequence conflict | 862 – 866 | 5 | YSSEE → FSVFF in BAB47420. Ref.5 | ||||||
| Sequence conflict | 1180 | 1 | Q → R in BAD96773. Ref.5 | ||||||
| Sequence conflict | 1356 | 1 | G → E in BAD96773. Ref.5 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A new subfamily of high molecular mass CDC2-related kinases with PITAI/VRE." Marques F., Moreau J.L., Peaucellier G., Lozano J.C., Schatt P., Picard A., Callebaut I., Perre E., Geneviere A.M. Biochem. Biophys. Res. Commun. 279:832-837(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), VARIANTS LEU-700 AND MET-1170. Tissue: Placenta. |
| [2] | NIEHS SNPs program Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ALA-356; PHE-403; GLN-410; ALA-500; GLY-624 AND MET-1062. |
| [3] | "The DNA sequence of human chromosome 7." Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., Delehaunty K.D., Miner T.L. Wilson R.K.Nature 424:157-164(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "Cloning and antisense oligodeoxynucleotide inhibition of a human homolog of cdc2 required in hematopoiesis." Lapidot-Lifson Y., Patinkin D., Prody C.A., Ehrlich G., Seidman S., Ben-Aziz R., Benseler F., Eckstein F., Zakut H., Soreq H. Proc. Natl. Acad. Sci. U.S.A. 89:579-583(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 361-1078, FUNCTION, VARIANT LEU-700. Tissue: Glioblastoma. |
| [5] | Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 856-1512 (ISOFORM 2). Tissue: Thyroid. |
| [6] | "Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O. DNA Res. 8:85-95(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 860-1512 (ISOFORM 1). Tissue: Brain. |
| [7] | "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry." Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C. Anal. Chem. 76:2763-2772(2004) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Leukemic T-cell. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1246, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "CDC2L5, a Cdk-like kinase with RS domain, interacts with the ASF/SF2-associated protein p32 and affects splicing in vivo." Even Y., Durieux S., Escande M.L., Lozano J.C., Peaucellier G., Weil D., Geneviere A.M. J. Cell. Biochem. 99:890-904(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH C1QBP. |
| [10] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Embryonic kidney. |
| [11] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [12] | "CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing." Berro R., Pedati C., Kehn-Hall K., Wu W., Klase Z., Even Y., Geneviere A.M., Ammosova T., Nekhai S., Kashanchi F. J. Virol. 82:7155-7166(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH HIV-1 TAT. |
| [13] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1246, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-317; SER-325; SER-340; SER-342; SER-383; SER-395; SER-397; SER-400; SER-437; SER-439 AND THR-871, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1048, MASS SPECTROMETRY. |
| [16] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Leukemic T-cell. |
| [17] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-556, MASS SPECTROMETRY. |
| [18] | "CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1." Bartkowiak B., Liu P., Phatnani H.P., Fuda N.J., Cooper J.J., Price D.H., Adelman K., Lis J.T., Greenleaf A.L. Genes Dev. 24:2303-2316(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY. |
| [19] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383; SER-437; SER-439; SER-525 AND THR-871, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [21] | "Genome-wide evaluation and discovery of vertebrate A-to-I RNA editing sites." Maas S., Godfried Sie C.P., Stoev I., Dupuis D.E., Latona J., Porman A.M., Evans B., Rekawek P., Kluempers V., Mutter M., Gommans W.M., Lopresti D. Biochem. Biophys. Res. Commun. 412:407-412(2011) [PubMed] [Europe PMC] [Abstract] Cited for: RNA EDITING OF POSITION 103. |
| [22] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-317; SER-383; SER-395; SER-397; SER-400; SER-437; SER-439; THR-871 AND THR-1246, MASS SPECTROMETRY. |
| [23] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] ALA-494; ALA-500; ARG-670 AND MET-1170. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AJ297709 mRNA. Translation: CAC10400.1. AJ297710 mRNA. Translation: CAC10401.1. AY679523 Genomic DNA. Translation: AAT74623.1. AC072061 Genomic DNA. Translation: AAS07490.1. Sequence problems. AC072061 Genomic DNA. Translation: AAS07491.1. AC006023 Genomic DNA. Translation: AAD54514.1. M80629 mRNA. Translation: AAA58424.1. Frameshift. AK223053 mRNA. Translation: BAD96773.1. AB058694 mRNA. Translation: BAB47420.1. |
| IPI | IPI00029162. IPI00456970. |
| PIR | A38197. |
| RefSeq | NP_003709.3. NM_003718.4. NP_112557.2. NM_031267.3. |
| UniGene | Hs.233552. |
3D structure databases | |
| ProteinModelPortal | Q14004. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q14004. 2 interactions. |
| MINT | MINT-1197921. |
| STRING | 9606.ENSP00000181839. |
PTM databases | |
| PhosphoSite | Q14004. |
Polymorphism databases | |
| DMDM | 66774048. |
Proteomic databases | |
| PaxDb | Q14004. |
| PRIDE | Q14004. |
Protocols and materials databases | |
| DNASU | 8621. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000181839; ENSP00000181839; ENSG00000065883. ENST00000340829; ENSP00000340557; ENSG00000065883. |
| GeneID | 8621. |
| KEGG | hsa:8621. |
| UCSC | uc003thh.4. human. uc003thi.4. human. |
Organism-specific databases | |
| CTD | 8621. |
| GeneCards | GC07P039957. |
| HGNC | HGNC:1733. CDK13. |
| MIM | 603309. gene. |
| neXtProt | NX_Q14004. |
| PharmGKB | PA26264. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0515. |
| HOVERGEN | HBG050851. |
| InParanoid | Q14004. |
| KO | K08819. |
| OMA | KERHREH. |
| OrthoDB | EOG4TTGH6. |
| PhylomeDB | Q14004. |
Gene expression databases | |
| Bgee | Q14004. |
| CleanEx | HS_CDC2L5. |
| Genevestigator | Q14004. |
| GermOnline | ENSG00000065883. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR002290. Ser/Thr_dual-sp_kinase_dom. IPR008271. Ser/Thr_kinase_AS. [Graphical view] |
| Pfam | PF00069. Pkinase. 1 hit. [Graphical view] |
| SMART | SM00220. S_TKc. 1 hit. [Graphical view] |
| SUPFAM | SSF56112. Kinase_like. 1 hit. |
| PROSITE | PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | Q14004. |
| ChEMBL | CHEMBL1795192. |
| GenomeRNAi | 8621. |
| NextBio | 32303. |
| PMAP-CutDB | Q14004. |
| SOURCE | Search... |
Entry information
| Entry name | CDK13_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q14004 Secondary accession number(s): Q53G78 Q9UDR4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
